Urinary tract infections (UTIs) are common bacterial infections affecting any part of the urinary system, including the kidneys, bladder, ureters, and urethra. Escherichia coli is a predominant causative agent, but other bacteria, viruses, or fungi can also lead to UTIs. Symptoms of UTIs may include frequent and painful urination, a strong urge to urinate, cloudy or foul-smelling urine, and pelvic pain. UTIs are more prevalent in women due to the shorter urethra, making it easier for bacteria to reach the bladder. Factors like sexual activity, urinary tract abnormalities, and a weakened immune system can increase the risk of UTIs. Diagnosis involves urine analysis, and treatment typically includes antibiotics to eliminate the infecting bacteria. Preventive measures include staying hydrated, practicing good hygiene, avoiding irritants like harsh soaps, and emptying the bladder regularly. Ongoing research focuses on understanding bacterial resistance, optimizing treatment regimens, and developing alternative preventive strategies for UTIs.
Khursheed Anwer
IMUNON, United States
Regina Au
BioMarketing Insight, United States
Madhu Khanna
University of Delhi, India
Khursheed Anwer
IMUNON, United States
Regina Au
BioMarketing Insight, United States
Madhu Khanna
University of Delhi, India
Lara Isis Teodoro
Mayo Clinic, United States
Ahmed Abdulazeez
BHRUT Trust, United Kingdom
Elena Chiappini
University of Florence, ItalySubmit your abstract Today
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe